BOXYM-N2 Handheld Medical Nebuliser with 3.7μm Particle Delivery for Respiratory Treatment

The BOXYM-N2 handheld medical nebuliser converts liquid medication into 3.7μm ± 25% particles that travel directly to respiratory tract and lung areas affected by conditions including colds, coughs, asthma, bronchitis and pneumonia. This direct delivery method works faster than oral medication while using only one-tenth the dosage, significantly reducing drug side effects particularly beneficial for children and elderly patients. Operating at ≤50dB(A) noise levels, the device creates a calmer treatment environment suitable for sensitive users across all age groups.

Technical Specifications and Performance Features

This section details the measurable performance data and construction elements that enable effective respiratory treatment through precise medication delivery and user-friendly operation.

Particle Size and Delivery Mechanism

The microporous nebuliser design generates 3.7μm ± 25% equivalent particle size that effectively reaches respiratory tract and lung areas through inhalation. This particle size range ensures medication reaches affected areas while maintaining consistent delivery at ≥0.2ml/min atomisation rate. The 108kHz nominal frequency operates with constant power to maintain treatment consistency throughout each session.

Noise and Power Specifications

Operating at ≤50dB(A) noise level, the nebuliser creates quieter treatment sessions compared to many conventional models. This reduced noise environment proves particularly valuable for children, elderly patients, and those requiring frequent treatments. The device offers dual power options through either USB connection or 2 x AA alkaline batteries, providing flexibility for home use or portable treatment situations.

Construction and Durability Details

Constructed from ABS plastic, the nebuliser maintains lightweight durability at 111.4g device weight without batteries. The 50 x 48 x 130mm dimensions create an ergonomic handheld design suitable for users of different ages and hand sizes. The low residual fluid design minimises medication waste while the water quantity inspection feature ensures proper operation before each use.

Practical Applications and Usage Scenarios

This section explores specific situations where the handheld nebuliser provides effective respiratory treatment across different user groups and environments, from clinical settings to home care situations.

Clinical and Home Healthcare Use

Medical professionals recommend this nebuliser for treating upper respiratory diseases including pharyngitis, rhinitis, bronchitis and pneumonia through direct medication delivery. The device's 3.7μm particle size ensures effective treatment while the reduced dosage requirement minimises systemic side effects. Healthcare providers appreciate the consistent ≥0.2ml/min delivery rate that maintains treatment protocol effectiveness across patient groups.

Everyday Family Respiratory Care

Families use this nebuliser for treating common conditions like colds, fever, cough and sore throat with reduced medication exposure. The ≤50dB(A) operation allows treatment during sleep or quiet times without disturbing household members. Parents particularly value the 90% dosage reduction for children's treatments, minimising potential side effects while maintaining therapeutic effectiveness for respiratory symptoms.

Portable Treatment Versatility

The 111.4g weight and dual power options enable treatment during travel, at work, or in various locations beyond traditional healthcare settings. Users maintain treatment consistency whether using USB power in vehicles or battery power in locations without electrical access. The compact 50 x 48 x 130mm size fits easily in bags while the ABS construction withstands regular portable use.

Treatment Benefits and User Advantages

This section examines the measurable benefits users experience through direct respiratory medication delivery, reduced side effects, and treatment flexibility across different situations and user requirements.

Medication Efficiency and Cost Value

The direct respiratory delivery method uses only 10% of typical oral medication dosage while achieving faster treatment results. This 90% reduction in medication requirement translates to significant cost savings over extended treatment periods. Patients experience reduced systemic side effects while achieving therapeutic outcomes through targeted delivery to affected respiratory areas.

Treatment Comfort and User Satisfaction

The ≤50dB(A) operation creates a calmer treatment experience particularly valuable for children, elderly patients, and those requiring frequent sessions. The 111.4g weight and ergonomic 50 x 48 x 130mm dimensions provide comfortable handling during typical 5-15 minute treatment sessions. Users appreciate the consistent ≥0.2ml/min delivery that maintains treatment effectiveness throughout each session.

Purchase Decision Considerations

This handheld nebuliser provides effective respiratory treatment with 90% medication reduction and quiet ≤50dB operation suitable for all age groups. The dual power options and portable 111.4g design offer treatment flexibility across home, travel, and healthcare environments. The direct 3.7μm particle delivery to respiratory areas ensures faster results than oral medication with significantly reduced side effects.